ATE132366T1 - Zusammensetzung zur behandlung von dry eye erkrankungen - Google Patents

Zusammensetzung zur behandlung von dry eye erkrankungen

Info

Publication number
ATE132366T1
ATE132366T1 AT91106698T AT91106698T ATE132366T1 AT E132366 T1 ATE132366 T1 AT E132366T1 AT 91106698 T AT91106698 T AT 91106698T AT 91106698 T AT91106698 T AT 91106698T AT E132366 T1 ATE132366 T1 AT E132366T1
Authority
AT
Austria
Prior art keywords
composition
treatment
dry eye
eye diseases
eye
Prior art date
Application number
AT91106698T
Other languages
English (en)
Inventor
Thomas Glonek
Donald R Korb
Jack V Greiner
Original Assignee
Boston Ocular Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Ocular Res filed Critical Boston Ocular Res
Application granted granted Critical
Publication of ATE132366T1 publication Critical patent/ATE132366T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
AT91106698T 1990-05-29 1991-04-25 Zusammensetzung zur behandlung von dry eye erkrankungen ATE132366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52965790A 1990-05-29 1990-05-29
US63821591A 1991-01-07 1991-01-07

Publications (1)

Publication Number Publication Date
ATE132366T1 true ATE132366T1 (de) 1996-01-15

Family

ID=27063077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91106698T ATE132366T1 (de) 1990-05-29 1991-04-25 Zusammensetzung zur behandlung von dry eye erkrankungen

Country Status (12)

Country Link
US (1) US5294607A (de)
EP (1) EP0459148B1 (de)
JP (1) JP3281392B2 (de)
AT (1) ATE132366T1 (de)
AU (1) AU648304B2 (de)
CA (1) CA2043366C (de)
DE (1) DE69115990T2 (de)
ES (1) ES2084722T3 (de)
GR (1) GR3019478T3 (de)
IL (1) IL98237A (de)
RU (1) RU2092138C1 (de)
TW (1) TW200396B (de)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
DE69629230D1 (de) * 1995-03-24 2003-09-04 Ocular Res Of Bonton Inc Hydrogellinse mit Lipid-Vorbeschichtigung
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
DE19527132A1 (de) * 1995-07-25 1997-01-30 Laevosan Gmbh & Co Kg Ophthalmologische Ozonschutzzusammensetzung
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
JPH10218760A (ja) * 1997-02-04 1998-08-18 Nobel Igaku Kenkyusho:Kk ドライアイ治療用の微量油添加目薬
ZA989513B (en) 1997-10-21 1999-04-21 Alcon Lab Inc Compositions containing histamine H2 agonists and methods of use in treating dry eye
RU2125427C1 (ru) * 1998-05-27 1999-01-27 Миронова Эмилия Михайловна Средство для лечения глазных заболеваний - оковидит
EP0982025A1 (de) * 1998-08-28 2000-03-01 Wilhelm Prof. Dr. Stoffel Künstliche Tränen
AU2183900A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
AU2183800A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of dry eye
US6281192B1 (en) 1999-03-01 2001-08-28 Vista Scientific Llc Mucin containing ophthalmic preparations
AUPQ228199A0 (en) * 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
WO2001034548A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use
TR200201244T2 (tr) 1999-11-09 2002-08-21 Alcon, Inc. Göz kurumasının iyileştirilmesi için Lipoksin A4 ve analogları
ATE257143T1 (de) 1999-11-09 2004-01-15 Alcon Inc 15-hydroxyeicosatetraensäure verwandte verbindungen und anwendungsverfahren
ES2235966T3 (es) 1999-11-09 2005-07-16 Alcon Inc. Analogos de acido 15-hidroxieicosatetraenoico con heteroatomos intercalados y metodos de uso.
US6552084B2 (en) 1999-11-09 2003-04-22 Alcon Universal Ltd. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
US6803385B2 (en) 1999-11-09 2004-10-12 Alcon, Inc. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
US6353032B1 (en) 1999-11-09 2002-03-05 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
US6458854B2 (en) 1999-11-09 2002-10-01 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
JP2003513950A (ja) 1999-11-09 2003-04-15 アルコン，インコーポレイテッド １５−ヒドロキシエイコサテトラエン酸のベンゼノイド誘導体およびドライアイ障害を処理するのに使用する方法
DK1228032T3 (da) 1999-11-09 2004-11-01 Alcon Inc Præparater, som indeholder hydroxyicosatetraensyrederivater, og fremgangsmåder til anvendelse ved behandling af öjentörhedslidelser
KR20020050237A (ko) 1999-11-09 2002-06-26 구이도 콜러, 스테판 바슬러 오메가 체인이 변형된 15-하이드록시에이코사테트라엔산유도체 및 안구 건조증의 치료를 위한 그들의 사용방법
AU1101301A (en) 1999-11-09 2001-06-06 Alcon Universal Limited 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
WO2001034550A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
CA2388044A1 (en) 1999-11-09 2001-05-17 Alcon, Inc. Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
WO2001046134A1 (en) 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
US6348508B1 (en) 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye
US7524511B1 (en) * 2000-07-12 2009-04-28 Rogue Valley Natural Springs, Inc. Method and kit for moisturizing the surface of the eye
DK1304991T3 (en) * 2000-07-12 2014-11-24 Rogue Valley Natural Springs Inc Method and kit for humidification of the surface of the eye
DE60213230T2 (de) 2001-05-21 2006-11-23 Alcon Inc. Verwendung von NF-Kappa.B Inhibitoren zur Behandlung von Augentrockenheit
DE60218153T2 (de) 2001-05-21 2007-06-28 Alcon Inc. Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
CN1239161C (zh) * 2001-05-21 2006-02-01 爱尔康公司 可用于治疗干眼疾病的类固醇
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
FR2827190A1 (fr) * 2001-06-22 2003-01-17 Rhodia Chimie Sa Utilisation d'une huile comprenant un groupement polaire comme aide au depot d'une huile polaire non ionisable
US6750250B1 (en) * 2001-07-12 2004-06-15 Alcon, Inc. 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
WO2003030893A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
WO2003030894A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
AU782913B2 (en) * 2001-11-02 2005-09-08 Santen Sas Method and composition for dry eye treatment
CA2484512C (en) * 2002-05-17 2013-04-16 Othera Pharmaceuticals, Inc. Treatment of cataracts and other ophthalmic diseases
PL374700A1 (en) * 2002-09-20 2005-10-31 Alcon, Inc. Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
US20060217325A1 (en) * 2002-12-20 2006-09-28 Alcon, Inc. Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells
US7235556B2 (en) 2003-04-16 2007-06-26 Alcon, Inc. Methods of treating dry eye disorders
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
WO2005025539A1 (ja) * 2003-09-10 2005-03-24 Senju Pharmaceutical Co., Ltd. コンタクトレンズ用眼科用組成物
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
US20070082017A1 (en) * 2004-01-10 2007-04-12 Tseng Scheffer C Lipid compositions and methods of use
US20050182039A1 (en) * 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye
DE602005016392D1 (de) 2004-03-25 2009-10-15 Bausch & Lomb Verwendung von loteprednoletabonat zur behanldung von trockenen augen
US7923471B2 (en) * 2004-05-14 2011-04-12 Alcon, Inc. Method of treating dry eye disorders and uveitis
CN100522147C (zh) * 2004-05-14 2009-08-05 爱尔康公司 5,6,7-三羟基庚酸及其类似物在制备治疗干眼病和眼色素层炎药物中的应用
CN101043884A (zh) * 2004-07-01 2007-09-26 谢彭斯眼科研究公司 用于治疗眼部疾病和病症的组合物和方法
JP5272307B2 (ja) * 2004-07-16 2013-08-28 大正製薬株式会社 水性点眼剤
US7223737B1 (en) 2004-08-13 2007-05-29 Alcon, Inc. Method of treating dry eye disorders using glycosides
KR20070061537A (ko) * 2004-08-27 2007-06-13 센주 세이야꾸 가부시키가이샤 건성안 치료용 안약액
WO2006065916A1 (en) * 2004-12-14 2006-06-22 Alcon, Inc. Method of treating dry eye disorders using 13(s)-hode and its analogs
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
AU2012201476B2 (en) * 2005-01-12 2014-07-17 Ocular Research Of Boston, Inc Dry eye treatment
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
HUE033304T2 (en) 2005-06-01 2017-11-28 Bioelectron Tech Corp Redoxactive therapeutic agents for the treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US20070004672A1 (en) * 2005-07-01 2007-01-04 Dharmendra Jani Long lasting alginate dry eye, related methods of manufacture and methods of use
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
JP6033177B2 (ja) * 2006-01-13 2016-11-30 大正製薬株式会社 Ｏ／ｗ型エマルション水性点眼剤
JP5748385B2 (ja) * 2006-01-13 2015-07-15 大正製薬株式会社 Ｏ／ｗ型エマルション水性点眼剤
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
ES2284398B2 (es) 2006-04-27 2008-12-16 Universidad Complutense De Madrid Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
EP2051736A2 (de) * 2006-07-07 2009-04-29 Bausch & Lomb Incorporated Zusammensetzungen mit einem dissoziierten glucocorticoid-rezeptor-agonisten und einem immunsuppressivum zur behandlung von trockenen augen
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
WO2008052037A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
WO2008052031A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. 2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
US20080188573A1 (en) * 2007-02-02 2008-08-07 Alcon Research, Ltd. Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
EP2155162B1 (de) * 2007-05-04 2012-11-21 Bausch & Lomb Incorporated Zusammensetzungen zur reduzierung, linderung, behandlung oder verhütung von trockenen augen und verfahren zu ihrer herstellung und verwendung
US20080280853A1 (en) * 2007-05-07 2008-11-13 Erning Xia Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
WO2008154129A1 (en) * 2007-06-08 2008-12-18 Bausch & Lomb Incorporated Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
BRPI0918139A2 (pt) 2008-09-10 2015-12-01 Edison Pharmaceuticals Inc composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
US20110195927A1 (en) * 2008-09-15 2011-08-11 Compositions Comprising Polymers Having Aminio Sugar Unites And Methods Of Making And Using Same Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same
US8539938B2 (en) * 2009-03-12 2013-09-24 Ford Global Technologies, Llc Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
PL2424495T3 (pl) 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
US8658614B2 (en) 2010-08-13 2014-02-25 The University of Texas Health Science Center Aptamer-containing compositions and methods for targeting E-selectin
US9161531B2 (en) 2011-02-23 2015-10-20 Donald R. Korb High alcohol content sanitizer
US8859525B2 (en) 2011-07-19 2014-10-14 Bausch & Lomb Incorporated Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
KR20140069210A (ko) 2011-09-22 2014-06-09 보오슈 앤드 롬 인코포레이팃드 안과적 겔 조성물
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US9278132B2 (en) 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
MX350201B (es) 2012-02-24 2017-08-30 Bausch & Lomb Composiciones oftalmicas con ceras alcoxiladas naturales.
JP6016465B2 (ja) * 2012-06-12 2016-10-26 ロート製薬株式会社 ビタミンａ類を含有する水性組成物
NZ732238A (en) 2012-08-10 2018-12-21 Osio Corp D/B/A Yolia Health Contact lens use in the treatment of an ophthalmologic condition
EP2948196B1 (de) 2013-01-24 2017-08-23 Bausch & Lomb Incorporated Poly(stickstoff/amin-)derivate eines natürlichen wachses oder ein alkoxyliertes derivat davon und ophthalmische zusammensetzungen daraus
EP3117210A4 (de) 2014-03-12 2017-11-01 University Of Virginia Patent Foundation Zusammensetzungen und verfahren zur behandlung von auegeninfektionen und -erkrankungen
US9505709B2 (en) 2014-05-05 2016-11-29 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
AU2015277509A1 (en) 2014-06-18 2017-01-05 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of active agents
EP3370718B1 (de) 2015-11-05 2021-01-27 University Of Louisville Research Foundation, Inc. Lokale und regionale anästhesie und analgesie
CN113024369A (zh) 2015-12-17 2021-06-25 Ptc医疗公司 用于治疗氧化应急障碍的化合物
CN109562186B (zh) 2016-06-03 2022-09-13 西蒂斯制药有限责任公司 与专门促消退介质的盐有关的组合物和方法
US9981041B2 (en) 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20180296390A1 (en) * 2017-04-18 2018-10-18 David Hoare Apparatus and method for treating a number of eye conditions of a user including dry eye syndrome and/or burns to the eyes
TW201938141A (zh) 2018-02-21 2019-10-01 瑞士商諾華公司 基於脂質的眼用乳劑
US11141348B2 (en) 2018-02-26 2021-10-12 Olympic Ophthalmics, Inc. Treatment methods using handheld devices for disorders
EP3893842A1 (de) * 2018-12-10 2021-10-20 Eternatear, Inc. Ophthalmische formulierungen zur bereitstellung von dauerhafter augenbenetzung
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4421748A (en) * 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
EP0316345A1 (de) * 1986-07-28 1989-05-24 Liposome Technology, Inc. Liposome mit verbesserter bindung an schleimgewebe
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions

Also Published As

Publication number Publication date
JPH04279525A (ja) 1992-10-05
TW200396B (de) 1993-02-21
CA2043366A1 (en) 1991-11-30
IL98237A (en) 1996-08-04
JP3281392B2 (ja) 2002-05-13
AU7619191A (en) 1992-08-06
IL98237A0 (en) 1992-06-21
US5294607A (en) 1994-03-15
GR3019478T3 (en) 1996-07-31
CA2043366C (en) 1999-01-05
EP0459148B1 (de) 1996-01-03
DE69115990D1 (de) 1996-02-15
ES2084722T3 (es) 1996-05-16
AU648304B2 (en) 1994-04-21
RU2092138C1 (ru) 1997-10-10
EP0459148A2 (de) 1991-12-04
EP0459148A3 (en) 1992-10-14
DE69115990T2 (de) 1996-05-30

Similar Documents

Publication Publication Date Title
ATE132366T1 (de) Zusammensetzung zur behandlung von dry eye erkrankungen
DE3874479T2 (de) Loesung zur behandlung von "dry-eye"-erkrankungen.
DE4391418T1 (de) Vorrichtung zur elektrochemischen Behandlung von Wasser
ES2145882T3 (es) Emulsion de agua-en-aceite sin agente tensioactivo.
DE69432228D1 (de) Fluorierte öl-in-wasser-emulsion zur oberflächenbehandlung
DE69304233D1 (de) Vorrichtung zur Behandlung von Wasser
DE69126776D1 (de) Parasitizide zusammensetzung und verfahren zu ihrer herstellung und ihre verwendung
DE69404785T2 (de) Vorrichtung zur Behandlung von Oberflächen
BE888082A (fr) Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau
DE69314234D1 (de) Konservierte Polysiloxanemulsion zur Behandlung von Geweben
DE68914657T2 (de) Vorrichtung zur herstellung von eiskugeln und anwendung derselben zwecks oberflächenbehandlung.
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
IT7924778A0 (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione.
DE69403871D1 (de) Vorrichtung zur Behandlung von Oberflächen
ATA345986A (de) Verfahren und vorrichtung zur konservatorischen behandlung von papier
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE68903930T2 (de) Lipidemulsion zur behandlung von aids.
ATE204337T1 (de) Verfahren zur behandlung von leder mit tensiden zur verbesserung der hydrophobierwirkung
DE69731981D1 (de) Neue verbesserte formulierung zur behandlung von thromboembolismus
EP0139460A3 (de) Benzodiazepine und ihre therapeutische Verwendung
DE59104484D1 (de) Verfahren und Vorrichtung zur Behandlung von feuchten Gas-Staub-Gemischen.
ES520268A0 (es) Procedimiento para producir un conjunto compuesto con accion sanitaria o higienica, tal como en desodorante ambiental,un cuerpo perfumante o similar.
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE9321428U1 (de) Konservierte Polysiloxanemulsionen zur Behandlung von Tissues
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee